UTIs

R&D

Why conditions like UTI call for new antibiotics

Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.

News

Rapid UTI tests could cut antibiotic resistance, says NICE

Rapid urine tests could help NHS ensure that antibiotics are used appropriately.

News

Ambros' $125m for pain disorder drug, and other financings

Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks